US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 0.580
  • +0.012+2.06%
Close Nov 18 16:00 ET
24.79MMarket Cap-284P/E (TTM)

BioXcel Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Nov 18, 2024

Based on 3 analysts giving stock ratings to BioXcel Therapeutics in the past 3 months

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

Updated: Nov 18, 2024

The average BioXcel Therapeutics stock price target is 5.00 with a max estimate of 5.00 and a min estimate of 5.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Nov 18, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

Updated: Nov 18, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data